← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Golden Helix, Inc.
Bozeman, MT
$6,294,882
Total funding
8
Grants
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,294,882 · 8
By mechanism
R44$5,489,304 · 4
R43$805,578 · 4
Investigators at Golden Helix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options$1,264,651
R44 · FY2025 · HG
Integrating CNV analysis into a NextGen sequencing clinical analytics platform$997,214
R44 · FY2018 · GM
Integrating CNV analysis into a NextGen sequencing clinical analytics platform$881,004
R44 · FY2019 · GM
Automated and Guided Workflows for Clinical Testing Using NGS Assays$672,214
R44 · FY2019 · GM
Automated and Guided Workflows for Clinical Testing Using NGS Assays$649,744
R44 · FY2020 · GM
Software Relating Genes to Disease and Clinical Outcomes$538,979
R44 · FY2003 · GM
Software Relating Genes to Disease and Clinical Outcomes$416,498
R44 · FY2004 · GM
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options$399,810
R43 · FY2023 · HG
Automated and Guided Workflows for Clinical Testing Using NGS Assays$156,162
R43 · FY2018 · GM
Integrating CNV analysis into a NextGen sequencing clinical analytics platform$149,956
R43 · FY2017 · GM
Software Relating Genes to Disease and Clinical Outcomes$99,650
R43 · FY2001 · GM
Software Relating Genes to Disease and Clinical Outcomes$69,000
R44 · FY2005 · GM